Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I: C administration

J. D. White, M. J. Eimerbrink, H. B. Hayes, A. Hardy, E. A. Van Enkevort, J. L. Peterman, M. J. Chumley, G. W. Boehm

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Alzheimer's disease is marked by the accumulation of the amyloid-beta (Aβ) peptide, and increases in phosphorylation of the microtubule associated protein, tau. Changes in these proteins are considered responsible, in part, for the progressive neuronal degeneration and cognitive deficits seen in AD. We examined the effect of repeated consecutive peripheral poly I:C injections on cognitive deficits, central Aβ, and phosphorylated tau accumulation, following three treatment durations: 7, 14, and 21 days. Forty-eight hours after the final injection, animals were trained in a contextual fear-conditioning paradigm, and tested 24 h later. Immediately after testing, the hippocampus was collected to quantify Aβ and phosphorylated tau accumulation. Results showed that, although poly I:C-induced Aβ was significantly elevated at all time points examined, poly I:C only disrupted cognition after 14 and 21 days of administration. Moreover, elevations in phosphorylated tau were not seen until the 14-day time point. Interestingly, phosphorylated tau expression then declined at the 21-day time point. Finally, we demonstrated that Aβ levels are a stronger predictor of cognitive dysfunction, explaining 37% of the variance, whereas phosphorylated tau levels only accounted for 0.2%. Taken together, these results support the hypothesis that inflammation-induced elevation in Aβ disrupts cognition, independently of phosphorylated tau, and suggest that long-term administration of poly I:C may provide a model to investigate the contribution of long-term inflammation toward the development of Alzheimer's-like pathology.

Original languageEnglish (US)
Pages (from-to)219-225
Number of pages7
JournalBehavioural Brain Research
Volume313
DOIs
StatePublished - Oct 15 2016

Fingerprint

Poly I-C
Cognition
Inflammation
Injections
Microtubule-Associated Proteins
Amyloid beta-Peptides
Fear
Hippocampus
Alzheimer Disease
Phosphorylation
Pathology
Proteins
Therapeutics

Keywords

  • Alzheimer's disease
  • Amyloid-beta
  • Cognition
  • Inflammation
  • Mice
  • Tau

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

White, J. D., Eimerbrink, M. J., Hayes, H. B., Hardy, A., Van Enkevort, E. A., Peterman, J. L., ... Boehm, G. W. (2016). Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I: C administration. Behavioural Brain Research, 313, 219-225. https://doi.org/10.1016/j.bbr.2016.07.032

Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I : C administration. / White, J. D.; Eimerbrink, M. J.; Hayes, H. B.; Hardy, A.; Van Enkevort, E. A.; Peterman, J. L.; Chumley, M. J.; Boehm, G. W.

In: Behavioural Brain Research, Vol. 313, 15.10.2016, p. 219-225.

Research output: Contribution to journalArticle

White, JD, Eimerbrink, MJ, Hayes, HB, Hardy, A, Van Enkevort, EA, Peterman, JL, Chumley, MJ & Boehm, GW 2016, 'Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I: C administration', Behavioural Brain Research, vol. 313, pp. 219-225. https://doi.org/10.1016/j.bbr.2016.07.032
White, J. D. ; Eimerbrink, M. J. ; Hayes, H. B. ; Hardy, A. ; Van Enkevort, E. A. ; Peterman, J. L. ; Chumley, M. J. ; Boehm, G. W. / Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I : C administration. In: Behavioural Brain Research. 2016 ; Vol. 313. pp. 219-225.
@article{df7c3999385348d1a956f0c8739ea6ac,
title = "Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I: C administration",
abstract = "Alzheimer's disease is marked by the accumulation of the amyloid-beta (Aβ) peptide, and increases in phosphorylation of the microtubule associated protein, tau. Changes in these proteins are considered responsible, in part, for the progressive neuronal degeneration and cognitive deficits seen in AD. We examined the effect of repeated consecutive peripheral poly I:C injections on cognitive deficits, central Aβ, and phosphorylated tau accumulation, following three treatment durations: 7, 14, and 21 days. Forty-eight hours after the final injection, animals were trained in a contextual fear-conditioning paradigm, and tested 24 h later. Immediately after testing, the hippocampus was collected to quantify Aβ and phosphorylated tau accumulation. Results showed that, although poly I:C-induced Aβ was significantly elevated at all time points examined, poly I:C only disrupted cognition after 14 and 21 days of administration. Moreover, elevations in phosphorylated tau were not seen until the 14-day time point. Interestingly, phosphorylated tau expression then declined at the 21-day time point. Finally, we demonstrated that Aβ levels are a stronger predictor of cognitive dysfunction, explaining 37{\%} of the variance, whereas phosphorylated tau levels only accounted for 0.2{\%}. Taken together, these results support the hypothesis that inflammation-induced elevation in Aβ disrupts cognition, independently of phosphorylated tau, and suggest that long-term administration of poly I:C may provide a model to investigate the contribution of long-term inflammation toward the development of Alzheimer's-like pathology.",
keywords = "Alzheimer's disease, Amyloid-beta, Cognition, Inflammation, Mice, Tau",
author = "White, {J. D.} and Eimerbrink, {M. J.} and Hayes, {H. B.} and A. Hardy and {Van Enkevort}, {E. A.} and Peterman, {J. L.} and Chumley, {M. J.} and Boehm, {G. W.}",
year = "2016",
month = "10",
day = "15",
doi = "10.1016/j.bbr.2016.07.032",
language = "English (US)",
volume = "313",
pages = "219--225",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I

T2 - C administration

AU - White, J. D.

AU - Eimerbrink, M. J.

AU - Hayes, H. B.

AU - Hardy, A.

AU - Van Enkevort, E. A.

AU - Peterman, J. L.

AU - Chumley, M. J.

AU - Boehm, G. W.

PY - 2016/10/15

Y1 - 2016/10/15

N2 - Alzheimer's disease is marked by the accumulation of the amyloid-beta (Aβ) peptide, and increases in phosphorylation of the microtubule associated protein, tau. Changes in these proteins are considered responsible, in part, for the progressive neuronal degeneration and cognitive deficits seen in AD. We examined the effect of repeated consecutive peripheral poly I:C injections on cognitive deficits, central Aβ, and phosphorylated tau accumulation, following three treatment durations: 7, 14, and 21 days. Forty-eight hours after the final injection, animals were trained in a contextual fear-conditioning paradigm, and tested 24 h later. Immediately after testing, the hippocampus was collected to quantify Aβ and phosphorylated tau accumulation. Results showed that, although poly I:C-induced Aβ was significantly elevated at all time points examined, poly I:C only disrupted cognition after 14 and 21 days of administration. Moreover, elevations in phosphorylated tau were not seen until the 14-day time point. Interestingly, phosphorylated tau expression then declined at the 21-day time point. Finally, we demonstrated that Aβ levels are a stronger predictor of cognitive dysfunction, explaining 37% of the variance, whereas phosphorylated tau levels only accounted for 0.2%. Taken together, these results support the hypothesis that inflammation-induced elevation in Aβ disrupts cognition, independently of phosphorylated tau, and suggest that long-term administration of poly I:C may provide a model to investigate the contribution of long-term inflammation toward the development of Alzheimer's-like pathology.

AB - Alzheimer's disease is marked by the accumulation of the amyloid-beta (Aβ) peptide, and increases in phosphorylation of the microtubule associated protein, tau. Changes in these proteins are considered responsible, in part, for the progressive neuronal degeneration and cognitive deficits seen in AD. We examined the effect of repeated consecutive peripheral poly I:C injections on cognitive deficits, central Aβ, and phosphorylated tau accumulation, following three treatment durations: 7, 14, and 21 days. Forty-eight hours after the final injection, animals were trained in a contextual fear-conditioning paradigm, and tested 24 h later. Immediately after testing, the hippocampus was collected to quantify Aβ and phosphorylated tau accumulation. Results showed that, although poly I:C-induced Aβ was significantly elevated at all time points examined, poly I:C only disrupted cognition after 14 and 21 days of administration. Moreover, elevations in phosphorylated tau were not seen until the 14-day time point. Interestingly, phosphorylated tau expression then declined at the 21-day time point. Finally, we demonstrated that Aβ levels are a stronger predictor of cognitive dysfunction, explaining 37% of the variance, whereas phosphorylated tau levels only accounted for 0.2%. Taken together, these results support the hypothesis that inflammation-induced elevation in Aβ disrupts cognition, independently of phosphorylated tau, and suggest that long-term administration of poly I:C may provide a model to investigate the contribution of long-term inflammation toward the development of Alzheimer's-like pathology.

KW - Alzheimer's disease

KW - Amyloid-beta

KW - Cognition

KW - Inflammation

KW - Mice

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=84979084518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979084518&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2016.07.032

DO - 10.1016/j.bbr.2016.07.032

M3 - Article

C2 - 27449203

AN - SCOPUS:84979084518

VL - 313

SP - 219

EP - 225

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -